Interim results from the ME&MGopen study demonstrate strong adherence, high usability, and meaningful clinical associations in myasthenia gravis PARIS, FRANCE, April 8, 2025 /EINPresswire.com/ -- Ad Scientiam to Present Promising Interim Findings on ...